Mode
Text Size
Log in / Sign up

Synchronized nasal intermittent positive pressure ventilation reduces extubation failure in preterm infants with respiratory distressSynchronized Ventilation May Reduce Extubation Failure in Preterm Infants

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider sNIPPV to improve breathing effort and reduce extubation failure in preterm infants with respiratory distress.

The meta-analysis investigated the efficacy of synchronized nasal intermittent positive pressure ventilation (sNIPPV) compared to nasal continuous positive airway pressure and standard nasal intermittent positive pressure ventilation in preterm infants experiencing respiratory distress. The primary focus was on extubation failure rates and secondary measures including breathing effort, patient-ventilator asynchrony, and synchronization rates.

The authors observed that sNIPPV was associated with a reduction in extubation failure compared to standard nasal continuous positive airway pressure. Additionally, sNIPPV was associated with improved breathing effort. Specific modes like neurally adjusted ventilatory assist demonstrated superior synchronization rates, shorter trigger delays, and lower patient-ventilator asynchrony compared to other sNIPPV modes.

Several limitations were noted, including a low to moderate risk of bias in the included studies. Most importantly, the authors highlighted that evidence regarding long-term major clinical outcomes remains limited. While sNIPPV provides consistent physiological and technical benefits, the long-term impact on infant health is not yet fully established. Clinicians should consider these findings as a basis for improving immediate respiratory management while remaining cautious regarding long-term prognostic implications.

Researchers analyzed data from 49 studies involving 2,864 preterm infants to compare different breathing support methods. The study looked at synchronized nasal intermittent positive pressure ventilation (sNIPPV) compared to standard nasal continuous positive airway pressure (nCPAP) and other ventilation modes.

The findings showed that infants using the synchronized method (sNIPPV) had a lower risk of extubation failure. These infants also showed improved breathing effort compared to those on standard nCPAP. Additionally, a specific mode called neurally adjusted ventilatory assist showed better synchronization and shorter delays in breathing triggers.

While these technical improvements are promising, the evidence for long-term clinical outcomes is still limited. Because this was a meta-analysis of various studies, the results show a link between the method and better breathing metrics, but they do not prove long-term health improvements. Talk to a medical professional to understand how these ventilation methods apply to specific patient needs.

What this means for you:
Synchronized ventilation may improve breathing effort and reduce extubation failure in preterm infants.

Common questions

What is the main benefit of synchronized ventilation for infants?

The study found that synchronized nasal intermittent positive pressure ventilation (sNIPPV) was linked to a lower risk of extubation failure compared to standard nCPAP. It also showed significantly improved breathing effort for the infants during treatment.

How does neurally adjusted ventilatory assist compare to other modes?

Neurally adjusted ventilatory assist showed higher synchronization rates (80% to 99%) and shorter trigger delays (35 ms) compared to other sNIPPV modes. It also showed lower patient-ventilator asynchrony, which helps the machine and the infant work together better.

Are there long-term benefits for the infants in this study?

While the study showed immediate technical and physiological benefits like better breathing effort, the evidence regarding long-term clinical outcomes for these infants remains limited. You should consult a doctor regarding the long-term outlook for specific cases.

Study Details

Study typeMeta analysis
EvidenceLevel 1
PublishedSep 2026
View Original Abstract ↓
BACKGROUND: Increasing evidence suggests that synchronised nasal intermittent positive pressure ventilation (sNIPPV) may be the optimal mode of non-invasive respiratory support. However, no comprehensive review of sNIPPV modes is available. This review aims to describe different synchronisation methods for sNIPPV and compare their effectiveness in clinical, physiological and technical outcomes with other modes of non-invasive respiratory support. METHODS: This review identified all clinical studies in preterm infants that compared sNIPPV to other non-invasive respiratory support modes or compared different trigger modalities between 1990 and 2026. A search was carried out in MEDLINE, Embase and the Cochrane Library. Main outcomes were categorised as clinical (eg, extubation failure (EF)), physiological (eg, breathing effort) and technical (eg, synchronisation rate). RESULTS: 49 studies (2864 infants) were included, with a low to moderate risk of bias. Meta-analysis showed a reduction in EF (risk ratio=0.38; 95% CI 0.17 to 0.85; p=0.03) in favour of sNIPPV compared with nasal continuous positive airway pressure (nCPAP). Physiological outcomes were significantly improved during sNIPPV compared with nCPAP and nasal intermittent positive pressure ventilation (NIPPV), especially breathing effort. When reviewing technical outcomes, non-invasive neurally adjusted ventilatory assist showed lower patient-ventilator asynchrony (PVA) (index ranging from 7% to 50%), a higher synchronisation rate (80%-99%) and a shorter trigger delay (35 ms) compared with other sNIPPV modes. CONCLUSIONS: This review shows that synchronising NIPPV results in consistent physiological (reduced patient effort) and technical benefits (reduced PVA). However, evidence on positive effects on (long-term) major clinical outcomes remains limited and requires further studies. PROSPERO REGISTRATION NUMBER: CRD420251022479.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.